Unspecified biological target

The term 'Unspecified biological target' is a descriptive classification used in pharmacology and drug discovery when a compound demonstrates a biological or therapeutic effect, but the specific molecular entity—such as a protein, enzyme, or receptor—with which it interacts is unknown. This situation frequently arises from phenotypic screening approaches, where drugs are identified based on their ability to modulate a complex biological system or disease phenotype rather than their binding to a specific pre-defined target. While these drugs can be effective, the lack of a defined target complicates the understanding of the mechanism of action and the prediction of potential side effects. Target deconvolution, the process of identifying the molecular targets of such compounds, is a critical step in modern drug development to enable more precise therapeutic interventions and safety assessments. Consequently, an 'unspecified target' represents a placeholder in biological databases until the underlying molecular interactions are elucidated through biochemical or proteomic studies.

Other names

Unknown targetUndisclosed targetUnidentified molecular target

The mechanism of action is unknown or not yet characterized at the molecular level because the specific target has not been identified.